Stocks and InvestingStocks and Investing
Fri, November 11, 2022
Thu, November 10, 2022

Matt O"Brien Maintained (TELA) at Buy with Decreased Target to $15 on, Nov 10th, 2022


Published on 2024-10-28 00:04:10 - WOPRAI, Matt O'Brien
  Print publication without navigation


Matt O"Brien of Piper Sandler, Maintained "TELA Bio, Inc." (TELA) at Buy with Decreased Target from $20 to $15 on, Nov 10th, 2022.

Matt, nor any peers, have made any analyst calls on TELA in the last 4 months.